116 related articles for article (PubMed ID: 80820)
1. Serum hormone levels in benign prostatic hyperplasia.
Sköldefors H; Blomstedt B; Carlström K
Scand J Urol Nephrol; 1978; 12(2):111-4. PubMed ID: 80820
[TBL] [Abstract][Full Text] [Related]
2. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of testosterone, LH and FSH after prostatic adenomectomy.
Fontana D; Isaia GC; Fasolis G; Tagliabue M; Randone DF
Andrologia; 1980; 12(6):556-8. PubMed ID: 6162405
[TBL] [Abstract][Full Text] [Related]
4. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
Tan MO; Karabiyik I; Uygur MC; Diker Y; Erol D
Int Urol Nephrol; 2003; 35(3):357-63. PubMed ID: 15160539
[TBL] [Abstract][Full Text] [Related]
7. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.
Wu Y; Pan H; Wang WM; Xu D; Zhang L; Gu ZQ; Bai Q; Qi J; Huang HF
Asian J Androl; 2017; 19(2):230-233. PubMed ID: 26763548
[TBL] [Abstract][Full Text] [Related]
8. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
Bartsch W; Becker H; Pinkenburg FA; Krieg M
Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
[TBL] [Abstract][Full Text] [Related]
9. Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
Madersbacher S; Schatzl G; Bieglmayer C; Reiter WJ; Gassner C; Berger P; Zidek T; Marberger M
Urology; 2002 Nov; 60(5):869-74. PubMed ID: 12429318
[TBL] [Abstract][Full Text] [Related]
10. Serum FSH, LH and prolactin in normal males and patients with prostatic diseases.
Hammond GL; Kontturi M; Määttälä P; Puukka M; Vihko R
Clin Endocrinol (Oxf); 1977 Aug; 7(2):129-35. PubMed ID: 70287
[TBL] [Abstract][Full Text] [Related]
11. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F
Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325
[No Abstract] [Full Text] [Related]
12. Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone.
Casarosa C; Cosci di Coscio M; Fratta M
Clin Ther; 1988; 10(5):585-8. PubMed ID: 2485240
[TBL] [Abstract][Full Text] [Related]
13. Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia.
Ansari MA; Begum D; Islam F
Ann Saudi Med; 2008; 28(3):174-8. PubMed ID: 18500180
[TBL] [Abstract][Full Text] [Related]
14. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
15. Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection.
Phadke MA; Vanage GR; Sheth AR
Prostate; 1987; 10(2):115-22. PubMed ID: 2436203
[TBL] [Abstract][Full Text] [Related]
16. [Pre- and post-prostatectomy variation and supplement of sexual hormones in patients with benign prostatic hyperplasia].
Ren XM; Ying J; Yao DH; Jiang YQ; Xu MX
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):50-2, 55. PubMed ID: 15704683
[TBL] [Abstract][Full Text] [Related]
17. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
[TBL] [Abstract][Full Text] [Related]
18. [Study of the interdependence between prostatic hypertrophy and disorders in hormone levels. Preliminary report. 1. Study of blood testosterone].
Szymanoski J; Baranowska B; Migdalska B; Kozlowicz I
J Urol Nephrol (Paris); 1976; 82(10-11):827-36. PubMed ID: 63569
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal disturbances in men with a prostatic adenoma (author's transl)].
Baranowska B; Zgliczynski S; Szymanowski J
J Urol (Paris); 1980; 86(7):551-8. PubMed ID: 6161196
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
Katayama T; Umeda K; Kazama T
Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
